
The Morning Brief Corner Office Conversation with The New Leaders of Indian Pharma
Aug 4, 2025
Sharvil Patel, Managing Director of Zydus Lifesciences, joins industry leaders to discuss India's transformative journey from a generics powerhouse to an innovation-driven biotech sector. They tackle the challenges of regulatory environments and pricing pressures while sharing insights on the importance of a robust R&D ecosystem. Patel emphasizes Zydus’ research-focused initiatives, while Namita Thapar highlights women's health advocacy, and Aman Mehta talks about shifting to a patient-centric approach. The conversation poses a vital question: Can India evolve from the 'pharmacy of the world' to its 'laboratory'?
AI Snips
Chapters
Transcript
Episode notes
India’s Global Pharma Leadership
- India is a global leader providing affordable generic medicines, with 1 in every 2 pills in the US made in India.
- This role underpins India's responsibility to improve healthcare access worldwide.
Harness Tech to Fix Healthcare
- Apply technology to solve awareness, access, and affordability issues in Indian healthcare.
- Collaborate legacy pharma players with startups to transform the healthcare ecosystem.
Innovation Beyond Generics
- The barriers to generic drug market entry are lowering, increasing competition.
- Investing in discovery and rare diseases can create unique impact and growth opportunities.
